References
- Kamerow DB, Pincus HA, MacDonald DI. Alcohol abuse, other drug abuse, and mental disorders in medical practice: prevalence, costs, recognition, and treatment JAMA 1986: 255(15): 2054–7
- Orangio GR, Pitlick SD, Delia Latta P, et al. Soft tissue infections in parenteral drug abusers. Ann Surg 1984: 199(1): 97–100
- Webb D, Thadepalli H. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs. West J Med 1979: 130(3): 200–4
- Reisberg BE. Infective endocarditis in the narcotic addict. Prog Cardiovasc Dis 1979: 22(3): 193–204
- Tuason CU, Sheagren JN. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 1975: 82(6): 788–90
- Robbins MJ, Soeiro R, Frishman WH, et al. Right-sided valvular endocarditis: etiology, diagnosis, and an approach to therapy. Am Heart J 1986: 111(1): 128–35
- Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 1986: 8(3): 374–96
- Barg NL, Kish MA, Kauffman CA, et al. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med 1985: 78(4): 569–74
- Holzman RS, Bishko F. Osteomyelitis in heroin addicts. Ann Intern Med 1971: 75(5): 693–6
- Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop 1979: 144(Oct): 238–48
- Sapico FL, Montgomerie JZ. Vertebral osteomyelitis in intravenous drug abusers: report of three cases and review of the literature. Rev Infect Dis 1980: 2(2): 196–206
- Goldin RH, Chow AW, Edwards JE Jr, et al. Sternoarticular septic arthritis in heroin users. N Engl J Med 1973: 289(12): 616–8
- Hoofnagle JH. Type B hepatitis: virology, serology and clinical course. Semin Liver Dis 1981: 1 (1): 7–14
- Perrillo RP, Asch RD. The clinical course and chronic sequelae of hepatitis B virus Infection. Semin Liver Dis 1981: 1(1): 15–25
- Govindarajan S, Chin KP, Redeker AG, et al. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984: 86(6): 1417–20
- Jacobson IM, Dienstag JL. The delta hepatitis agent: “viral hepatitis, type D.” Gastroenterology 1984: 86(6): 1614–7
- Dienstag J. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983: 85(2): 439–62
- Weinstein L. Tetanus. N Engl J Med 1973: 289(24): 1293–6
- Blake PA, Feldman RA. Tetanus in the United States. 1970–1971. J Infect Dis 1975: 131(6): 745–8
- Leads from the MMWR. Revision of the CDC surveillance case definition for acquired Immunodeficiency syndrome. JAMA 1987: 258(9): 1143–5. 1149, 1153–4
- Friedland GH, Klein RS. Transmission of the human immunodeficiency virus. N Engl J Med 1987: 317(18): 1125–35
- Fauci AS, Masur H, Gelmann EP, et al. The acquired immunodeficiency syndrome: an update. Ann Intern Med 1985: 102(6): 800–13
- Gabuzda DH, Hirsch MS. Neurologic manifestations of infection with human immunodeficiency virus: clinical features and pathogenesis. Ann Intern Med 1987: 107(3): 383–91